Archives
-
NVP-BGJ398 Phosphate: From Signal to Phenotype
2026-09-22
NVP-BGJ398 phosphate is a selective FGFR1–3 inhibitor that connects genotype-defined cancer models with FGFR3-dependent skeletal research. This article explains how to convert pathway suppression into rigorous, phenotype-level evidence using orthogonal assays.
-
NVP-BGJ398 phosphate: FGFR Research Workflows
2026-09-22
NVP-BGJ398 phosphate enables mechanism-focused inhibition of FGFR1–3 across cancer, chondrocyte, and signaling assays. This practical guide connects genotype-aware screening with phospho-FGFR and ERK1/2 validation, while addressing dosing, solubility, and assay reproducibility.
-
ATRX Loss Sensitizes High-Grade Glioma to RTK Inhibitors
2026-09-21
The reference study identifies ATRX deficiency as a potential biomarker of increased sensitivity to multi-targeted receptor tyrosine kinase and PDGFR inhibitors in high-grade glioma cells. Its combination experiments further suggest that pairing these inhibitors with temozolomide may intensify toxicity in ATRX-deficient models, supporting ATRX-aware interpretation of translational studies.
-
DPPH Antioxidant Screening: Workflow & Tips
2026-09-21
Build a reproducible DPPH workflow for rapid in vitro antioxidant screening, natural-product prioritization, and high-throughput compound comparison. Practical solvent guidance, plate controls, and troubleshooting help distinguish true radical scavenging from color, precipitation, and matrix artifacts.
-
Cabamiquine Pharmacodynamics: Fast Arrest, Slow Clearance
2026-09-20
The reference study separates cabamiquine-induced translational arrest from subsequent parasite killing using complementary luminescence, viability, growth, and live-imaging assays. Its findings explain how a drug can act rapidly at the molecular level while producing delayed blood-stage clearance, an important distinction for interpreting antimalarial pharmacodynamics.
-
KNUCKLES Controls Floral Meristem Termination
2026-09-19
The Arabidopsis study shows that KNUCKLES terminates floral meristem activity by coordinating the established WUS–CLV3 stem-cell circuit with auxin distribution and cytokinin biosynthesis. Its central advance is the identification of PIN1 and IPT7 as chromatin-linked targets through which KNU-associated H3K27me3 deposition helps impose floral determinacy.
-
PPARγ, Macrophage Polarization, and DSS-Induced IBD
2026-09-18
This study identifies PPARγ activation as a regulator of macrophage polarization in dextran sulfate sodium-induced inflammatory bowel disease, linking reduced M1 activity and enhanced M2 features to reciprocal changes in STAT-1 and STAT-6 signaling. Its combined cell and mouse experiments provide a mechanistic framework for studying inflammatory process modulation, while also highlighting the limits of translating a chemically induced model into human IBD.
-
mRNA Vaccine Immune Memory and LNP Design
2026-09-18
The reference study shows that durable mRNA vaccine protection depends on strengthening immune memory against tumor antigens while limiting memory directed toward lipid nanoparticles. Its SAPC-LNP design combines sialic acid-mediated dendritic-cell targeting with cleavable PEG to improve endosomal escape, reduce repeated-dose liabilities, and sustain antitumor protection.
-
Annexin V-FITC/7-AAD Apoptosis Kit Workflow
2026-09-17
Build a rapid cell death analysis workflow that separates viable, early apoptotic, late apoptotic, and necrotic populations in one assay. The approach also shows how lactoferrin-processing studies can be translated into practical cell viability and cytotoxicity readouts without overstating what Annexin V can prove mechanistically.
-
E. tenella Drugs, Cecal Microbiota, and Metabolomics
2026-09-17
The reference study combines 16S rRNA gene sequencing with LC-MS/MS metabolomics to examine how ethanamizuril, sulfachlorpyridazine, and their combination affect chickens infected with Eimeria tenella. Its main contribution is a systems-level view of anticoccidial efficacy, showing that treatment-associated microbial and metabolic changes can provide context for interpreting intestinal health and drug response.
-
Nirmatrelvir (PF-07321332) Research Workflows
2026-09-16
Build mechanism-first SARS-CoV-2 assays around Nirmatrelvir (PF-07321332), from 3CL protease cleavage measurements to cell-based replication studies. This guide combines practical handling, assay controls, docking-informed validation, and troubleshooting for antiviral therapeutics research.
-
Praeruptorin A: From Target to Translational Assay
2026-09-16
Praeruptorin A is an angular pyranocoumarin compound that links DMT1-dependent iron handling with ferroptosis, inflammation, and tissue injury. This article presents a decision-based framework for selecting assays, interpreting orthogonal readouts, and translating findings across cardiomyopathy, colitis, and tumor-invasion models.
-
Isorhamnetin in Oocyte Stress Assays
2026-09-15
Isorhamnetin offers a practical way to connect oocyte maturation phenotypes with oxidative stress, apoptosis, endoplasmic-reticulum homeostasis, and PI3K/Akt signaling. This guide translates the reference findings into concentration-controlled workflows, assay controls, and troubleshooting decisions for reproducible cellular research.
-
N2703 in Adipose-Neural Arrhythmia Models
2026-09-15
Explore how 3-(1-methylpyrrolidin-2-yl)pyridine (N2703) can be incorporated as a hypothesis-generating perturbation in adipocyte–sympathetic neuron–cardiomyocyte assays. The workflow emphasizes concentration control, vehicle-matched controls, electrophysiology readouts, and careful separation of product-enabled observations from mechanisms established in the reference study.
-
JNJ-26854165: Assay Workflows for p53 Studies
2026-09-14
JNJ-26854165 (Serdemetan) supports mechanism-focused studies of HDM2 inhibition, p53 stabilization, proliferation arrest, and apoptosis. A workflow that separates relative viability from fractional viability can reveal whether treatment primarily slows growth, kills cells, or produces both effects over different time windows.